Abstract
Heparan sulfate proteoglycans are abundant matrix and membrane molecules. Smooth muscle specific deletion of one heparan sulfate biosynthetic enzyme, N-deacetylase-N-sulfotransferase1 leads to decreased vascular smooth muscle cell proliferation, and vascular wall thickness. We hypothesized that this may lead to changes in blood pressure in conscious mice. Blood pressure was measured via telemetry in SM22αCre+Ndst1−/−(n = 4) and wild type (n = 8) mice. Aorta and thoracodorsal artery luminal area is significantly smaller in SM22αCre+Ndst1−/− (n = 4–8, P = 0.02, P = 0.0002) compared to wild type (n = 7) mice. Diurnal differences were observed in both cohorts for systolic, diastolic, mean arterial blood pressure, and heart rate (P < 0.001 from T test). No significant differences were found in the above parameters between the cohorts in either light or dark times using a linear mixed model. In conclusion, deletion of N-deacetylase-N-sulfotransferase1 in smooth muscle did not influence any of the blood pressure parameters measured despite significant decrease in aorta and thoracodorsal artery luminal area.
Similar content being viewed by others
References
Esko, J. D., & Selleck, S. B. (2002). Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annual Review of Biochemistry, 71, 435–471.
Bishop, J. R., Schuksz, M., & Esko, J. D. (2007). Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature, 446(7139), 1030–1037.
Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annual Review of Biochemistry, 68, 729–777.
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006). VEGF receptor signalling? In control of vascular function. Nature Reviews Molecular Cell Biology, 7(5), 359–371.
Iozzo, R. V., & San Antonio, J. D. (2001). Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. Journal of Clinical Investigation, 108(3), 349–355.
Jakobsson, L., Kreuger, J., Holmborn, K., Lundin, L., Eriksson, I., Kjellen, L., & Claesson-Welsh, L. (2006). Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Developmental Cell, 10(5), 625–634.
Kirn-Safran, C. B., D’Souza, S. S., & Carson, D. D. (2008). Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation. Seminars in Cell & Developmental Biology, 19(2), 187–193.
Kirkpatrick, C. A., & Selleck, S. B. (2007). Heparan sulfate proteoglycans at a glance. Journal of Cell Science, 120(Pt 11), 1829–1832.
Rudd. T.R. and Yates, E.A. (2012). A highly efficient tree structure for the biosynthesis of heparan sulfate accounts for the commonly observed disaccharides and suggests a mechanism for domain synthesis. Molecular BioSystems.
Adhikari, N., Basi, D. L., Townsend, D., Rusch, M., Mariash, A., Mullegama, S., Watson, A., Larson, J., Tan, S., Lerman, B., Esko, J. D., Selleck, S. B., & Hall, J. L. (2010). Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling. Journal of Molecular and Cellular Cardiology, 49(2), 287–293.
Adhikari, N., Rusch, M., Mariash, A., Li, Q., Selleck, S. B., & Hall, J. L. (2008). Alterations in heparan sulfate in the vessel in response to vascular injury in the mouse. Journal of Cardiovascular Translational Research, 1(3), 236–240.
Zhao, X., Ho, D., Gao, S., Hong, C., Vatner, D.E., Vatner, S.F. (2011) Arterial Pressure Monitoring in Mice, in Current Protocols in Mouse Biology. Wiley
Desjardins, F., Lobysheva, I., Pelat, M., Gallez, B., Feron, O., Dessy, C., & Balligand, J.-L. (2008). Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis. Cardiovascular Research, 79(3), 527–536.
Kramer, K., & Kinter, L. B. (2003). Evaluation and applications of radiotelemetry in small laboratory animals. Physiological Genomics, 13(3), 197–205.
Fan, G., Xiao, L., Cheng, L., Wang, X., Sun, B., & Hu, G. (2000). Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Letters, 467, 7–11.
Ringvall, M., Ledin, J., Holmborn, K., van Kuppevelt, T., Ellin, F., Eriksson, I., Olofsson, A. M., Kjellen, L., & Forsberg, E. (2002). Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. Journal of Biological Chemistry, 75, 25926–25930.
Forsberg, E., & Kjellen, L. (2001). Heparan sulfate: lessons from knockout mice. The Journal of Clinical Investigation, 108(2), 175–180.
Francis, D.J., Parish, C.R., McGarry, M., Santiago, F.S., Lowe, H.C., Brown, K.J., Bingley, J.A., Hayward, I.P., Cowden, W.B., Campbell, J.H., Campbell, G.R., Chesterman, C.N., Khachigian, L.M. (2003). Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation. 92(8): p. e70.
Grobe, K., Inatani, M., Pallerla, S. R., Castagnola, J., Yamaguchi, Y., & Esko, J. D. (2005). Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development, 132, 3777–3786.
Kinnunen, T., Huang, Z., Townsend, J., Gatdula, M. M., Brown, J. R., Esko, J. D., & Turnbull, J. E. (2005). Heparan 2-O-sulfotransferase, hst-2, is essential for normal cell migration in Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America, 102(5), 1507–1512.
Pan, Y., Woodbury, A., Esko, J. D., Grobe, K., & Zhang, X. (2006). Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. Development, 133(24), 4933–4944.
Pallerla, S. R., Pan, Y., Zhang, X., Esko, J. D., & Grobe, K. (2007). Heparan sulfate Ndst1 gene function variably regulates multiple signaling pathways during mouse development. Developmental Dynamics, 236(2), 556–563.
Wang, L., Fuster, M., Sriramarao, P., & Esko, J. D. (2005). Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nature Immunology, 6(9), 902–910.
Lepore, J. J., Cheng, L., Lu, M. M., Mericko, P. A., Morrisey, E. E., & Parmacek, M. S. (2005). High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice. Genesis, 41(4), 179–184.
Frutkin, A. D., Shi, H., Otsuka, G., Leveen, P., Karlsson, S., & Dichek, D. A. (2006). A critical developmental role for tgfbr2 in myogenic cell lineages is revealed in mice expressing SM22-Cre, not SMMHC-Cre. Journal of Molecular and Cellular Cardiology, 41(4), 724–731.
Grobe, K., Inatani, M., Pallerla, S. R., Castagnola, J., Yamaguchi, Y., & Esko, J. D. (2005). Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development, 132(16), 3777–3786.
Franklin, S. S., Larson, M. G., Khan, S. A., Wong, N. D., Leip, E. P., Kannel, W. B., & Levy, D. (2001). Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation, 103(9), 1245–1249.
Gillum, R. F. (1987). The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18–79 years. Journal of Chronic Diseases, 40(5), 421–428.
Levy, O., Dayan, T., & Kronfeld-Schor, N. (2007). The Relationship between the Golden Spiny Mouse Circadian System and its diurnal activity: an experimental field enclosures and laboratory study. Chronobiology International, 24(4), 599–613.
Pallerla, S. R., Lawrence, R., Lewejohann, L., Pan, Y., Fischer, T., Schlomann, U., Zhang, X., Esko, J. D., & Grobe, K. (2008). Altered heparan sulfate structure in mice with deleted NDST3 gene function. Journal of Biological Chemistry, 283(24), 16885–16894.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Montaniel, K.R.C., Billaud, M., Graham, C. et al. Smooth Muscle Specific Deletion of Ndst1 Leads to Decreased Vessel Luminal Area and No Change in Blood Pressure in Conscious Mice. J. of Cardiovasc. Trans. Res. 5, 274–279 (2012). https://doi.org/10.1007/s12265-012-9369-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-012-9369-4